MediMabBio

Seongnam, South Korea · Founded 2017 · Privately Held (backing)

Developer of healthcare immunotherapies designed to treat serious diseases such as cancer and autoimmune disorders. MediMabBio is based in Seongnam, South Korea and was founded in 2017. It has raised $37.9 million.

Last price · $/share
—
Implied valuation
—
Total raised
$37.9M
Last round
—

Who backs MediMabBio?

19 investors
InvestorType
Tech Incubator Program for StartupOther
KB InvestmentVenture capital
Smilegate InvestmentVenture capital
Posco InvestmentVenture capital
iM Investment PartnersVenture capital
Yuanta InvestmentVenture capital
Timefolio Asset ManagementHedge fund
E&Venture PartnersVenture capital
Hyundai Investment PartnersAsset manager
HLB BioStep CompanyOther
+ 9 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

MediMabBio investors

19 investors are on record for MediMabBio, including Tech Incubator Program for Startup, KB Investment, Smilegate Investment and Posco Investment. By type, the record holds 6 venture capital firms and 1 hedge fund.

Free account
More of MediMabBio with a free account
  • ·The complete investor list: 19 names
  • ·Watch MediMabBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 19 firms already write checks for companies like MediMabBio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View